Xiaoyang Shi
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Association between impaired peripheral thyroid hormone sensitivity and coronary heart disease in type 2 diabetes: the potential mediating role of albumin.
Journal: Frontiers in endocrinology
Published: March 26, 2026
Gut microbiota and its metabolites promote painful diabetic peripheral neuropathy complicated with cognitive dysfunction in mice.
Journal: Frontiers in cellular and infection microbiology
Published: March 28, 2025
Identification and validation of palmitoylation-related biomarkers in gestational diabetes mellitus.
Identification and validation of palmitoylation-related biomarkers in gestational diabetes mellitus.
Journal: Scientific reports
Published: October 27, 2024
Tangeretin Enhances Muscle Endurance and Aerobic Metabolism in Mice via Targeting AdipoR1 to Increase Oxidative Myofibers.
Journal: Journal of agricultural and food chemistry
Published: July 11, 2024
Guild-level signature of gut microbiome for diabetic kidney disease.
Journal: mBio
Published: May 31, 2024
Alteration in gut microbiota is associated with immune imbalance in Graves' disease.
Journal: Frontiers in cellular and infection microbiology
Published: December 04, 2023
Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes.
Journal: Cell metabolism
Published: July 13, 2022
Sesamin Activates Skeletal Muscle FNDC5 Expression and Increases Irisin Secretion via the SIRT1 Signaling Pathway.
Journal: Journal of agricultural and food chemistry
Published: June 16, 2022
Vertical transmission of the gut microbiota influences glucose metabolism in offspring of mice with hyperglycaemia in pregnancy.
Journal: Microbiome
Published: January 31, 2022
Erratum. Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control Study. Diabetes Care 2021;44:2738-2746.
Journal: Diabetes care
Published: January 12, 2022
Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 29, 2021
Last Updated: 09/26/2026